Stock Scorecard
Stock Summary for Nutex Health Inc (NUTX) - $125.57 as of 10/25/2025 5:53:14 AM EST
Total Score
17 out of 30
Safety Score
55 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for NUTX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NUTX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NUTX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NUTX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NUTX (55 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 10 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for NUTX
Financial Details for NUTX
Company Overview |
|
|---|---|
| Ticker | NUTX |
| Company Name | Nutex Health Inc |
| Country | USA |
| Description | Nutex Health Inc. is a pioneering healthcare services provider headquartered in Houston, Texas, dedicated to enhancing patient outcomes through innovative technology and value-based care. The company operates a network of urgent care facilities and outpatient services, emphasizing high-quality care and operational efficiency. With a strong commitment to improving the healthcare experience, Nutex Health is strategically positioned to meet the increasing demand for accessible healthcare solutions, effectively addressing the evolving dynamics of the healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL CARE FACILITIES |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 125.57 |
| Price 4 Years Ago | 618.00 |
| Last Day Price Updated | 10/25/2025 5:53:14 AM EST |
| Last Day Volume | 103,279 |
| Average Daily Volume | 127,970 |
| 52-Week High | 184.28 |
| 52-Week Low | 21.55 |
| Last Price to 52 Week Low | 482.69% |
Valuation Measures |
|
| Trailing PE | 2.19 |
| Industry PE | 24.26 |
| Sector PE | 41.00 |
| 5-Year Average PE | -208.97 |
| Free Cash Flow Ratio | 8.23 |
| Industry Free Cash Flow Ratio | 33.24 |
| Sector Free Cash Flow Ratio | 29.25 |
| Current Ratio Most Recent Quarter | 2.27 |
| Total Cash Per Share | 15.25 |
| Book Value Per Share Most Recent Quarter | 35.65 |
| Price to Book Ratio | 3.02 |
| Industry Price to Book Ratio | 18.22 |
| Sector Price to Book Ratio | 32.16 |
| Price to Sales Ratio Twelve Trailing Months | 1.04 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.80 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 5,555,100 |
| Market Capitalization | 697,553,907 |
| Institutional Ownership | 33.07% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 213.96% |
| Reported EPS 12 Trailing Months | 53.65 |
| Reported EPS Past Year | 11.12 |
| Reported EPS Prior Year | 9.27 |
| Net Income Twelve Trailing Months | 67,177,243 |
| Net Income Past Year | 52,179,168 |
| Net Income Prior Year | -45,786,614 |
| Quarterly Revenue Growth YOY | 214.00% |
| 5-Year Revenue Growth | 37.67% |
| Operating Margin Twelve Trailing Months | 34.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 84,729,000 |
| Total Cash Past Year | 43,581,412 |
| Total Cash Prior Year | 22,002,056 |
| Net Cash Position Most Recent Quarter | 62,996,000 |
| Net Cash Position Past Year | 21,115,516 |
| Long Term Debt Past Year | 22,465,896 |
| Long Term Debt Prior Year | 26,314,733 |
| Total Debt Most Recent Quarter | 21,733,000 |
| Equity to Debt Ratio Past Year | 0.87 |
| Equity to Debt Ratio Most Recent Quarter | 0.90 |
| Total Stockholder Equity Past Year | 146,344,749 |
| Total Stockholder Equity Prior Year | 61,453,190 |
| Total Stockholder Equity Most Recent Quarter | 197,108,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 69,432,910 |
| Free Cash Flow Per Share Twelve Trailing Months | 12.50 |
| Free Cash Flow Past Year | 20,849,910 |
| Free Cash Flow Prior Year | -8,240,380 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 4.13 |
| MACD Signal | 2.80 |
| 20-Day Bollinger Lower Band | 74.90 |
| 20-Day Bollinger Middle Band | 102.21 |
| 20-Day Bollinger Upper Band | 129.52 |
| Beta | 1.98 |
| RSI | 65.95 |
| 50-Day SMA | 71.60 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 207.51 |
System |
|
| Modified | 10/25/2025 5:54:01 AM EST |